Susquehanna International Group, LLP Immunome Inc. Put Options Transaction History

Susquehanna International Group, LLP

  • $560 Billion
  • Q3 2024

Put Options

6 transactions
Quarter Operation Price Per put puts change puts Held SEC Form
Q3 2024

Nov 14, 2024
SELL
$11.7 - $16.51 $141,570 - $199,771
-12,100 Reduced 28.27%
30,700 $448,000
Q2 2024

Aug 15, 2024
BUY
$11.54 - $22.11 $268,882 - $515,163
23,300 Added 119.49%
42,800 $517,000
Q1 2024

May 07, 2024
BUY
$11.01 - $27.34 $214,695 - $533,130
19,500 New
19,500 $481,000
Q3 2023

Nov 14, 2023
SELL
$6.17 - $9.16 $21,595 - $32,060
-3,500 Reduced 16.99%
17,100 $142,000
Q2 2023

Aug 11, 2023
BUY
$4.7 - $7.91 $6,580 - $11,074
1,400 Added 7.29%
20,600 $162,000
Q1 2023

May 16, 2023
BUY
$3.26 - $5.69 $62,591 - $109,248
19,200 New
19,200 $95,000

Others Institutions Holding IMNM

# of Institutions
121
Shares Held
47.1M
Call Options Held
322K
Put Options Held
1.91M
View Full List

About Immunome Inc.

IMNM Quotes by TradingView
  • Ticker IMNM
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 12,127,400
  • Market Cap $135M
  • Description
  • Immunome, Inc., a biopharmaceutical company, discovers and develops antibody therapeutics for oncology and infectious disease. The company's lead oncology program includes IMM-ONC-01, which targets IL-38 tumor-derived immune checkpoint capable of promoting evasion of the immune system. It also develops IMM-BCP-01, an antibody cocktail product ca...
More about IMNM
Track This Portfolio

Track Susquehanna International Group, LLP Portfolio

Follow Susquehanna International Group, LLP and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Susquehanna International Group, LLP, based on Form 13F filings with the SEC.

News

Stay updated on Susquehanna International Group, LLP with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email